Skip to main content
Top
Published in: Annals of Hematology 5/2007

01-05-2007 | Original Article

Fusion of H4/D10S170 to PDGFRβ in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib

Authors: Matthias Drechsler, Barbara Hildebrandt, Andrea Kündgen, Ulrich Germing, Brigitte Royer-Pokora

Published in: Annals of Hematology | Issue 5/2007

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Cross NCP, Reiter A (2002) Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 16:1207–1212PubMedCrossRef Cross NCP, Reiter A (2002) Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 16:1207–1212PubMedCrossRef
2.
go back to reference Schwaller J, Anastasiadou E, Cain D, Kutok J, Woyiski S, Willimas IR, LaStarza R, Crescendi B, Sternberg DW, Andreason P, Schiavo R, Siena S, Mecucci C, Gilliland GD (2001) H4(D10S170), a gene frequently rearranged in papillary thyroid carcinomas, is fused to the platelet-derived growth factor receptor β gene in atypical chronic myeloid leukaemia with t(5;10)(q33;q22). Blood 97:3910–3918PubMedCrossRef Schwaller J, Anastasiadou E, Cain D, Kutok J, Woyiski S, Willimas IR, LaStarza R, Crescendi B, Sternberg DW, Andreason P, Schiavo R, Siena S, Mecucci C, Gilliland GD (2001) H4(D10S170), a gene frequently rearranged in papillary thyroid carcinomas, is fused to the platelet-derived growth factor receptor β gene in atypical chronic myeloid leukaemia with t(5;10)(q33;q22). Blood 97:3910–3918PubMedCrossRef
3.
go back to reference Kulkarni S, Heath C, Parker S, Chase A, Iqbal A, Pocock F, Kaeda J, Cwynarski K, Goldman JM, Cross NCP (2000) Fusion of H4/D10S170 to the platelet-derived growth factor receptor β in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res 60:3592–3598PubMed Kulkarni S, Heath C, Parker S, Chase A, Iqbal A, Pocock F, Kaeda J, Cwynarski K, Goldman JM, Cross NCP (2000) Fusion of H4/D10S170 to the platelet-derived growth factor receptor β in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res 60:3592–3598PubMed
4.
go back to reference Garcia JL, FontdeMora J, Hernandez JM, Queizan JA, Gutierrez NC, Hernandez JM San Miguel JF (2003) imatinib mesylat elicts positive clinical response in atypical chronic myeloid leukaemia involving the platelet-derived growth factor receptor beta. Blood 102:2699–2700PubMedCrossRef Garcia JL, FontdeMora J, Hernandez JM, Queizan JA, Gutierrez NC, Hernandez JM San Miguel JF (2003) imatinib mesylat elicts positive clinical response in atypical chronic myeloid leukaemia involving the platelet-derived growth factor receptor beta. Blood 102:2699–2700PubMedCrossRef
5.
go back to reference Bastie J-N, Garcia I, Terré C, Cross NCP, Mahon F-X, Castaigne S (2004) Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor β-gene. Haematologica 89:1263–1264PubMed Bastie J-N, Garcia I, Terré C, Cross NCP, Mahon F-X, Castaigne S (2004) Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor β-gene. Haematologica 89:1263–1264PubMed
Metadata
Title
Fusion of H4/D10S170 to PDGFRβ in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib
Authors
Matthias Drechsler
Barbara Hildebrandt
Andrea Kündgen
Ulrich Germing
Brigitte Royer-Pokora
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 5/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0247-5

Other articles of this Issue 5/2007

Annals of Hematology 5/2007 Go to the issue